Q9Y5Y6 (ST14_HUMAN) Homo sapiens (Human)

Suppressor of tumorigenicity 14 protein UniProtKBInterProSTRINGInteractive Modelling

855 aa; Sequence (Fasta)

Available Structures

24 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of matriptase in complex with inhibitor Heteromer
604-855
NT4;
Assess
CRYSTAL STRUCTURE of MATRIPTASE in COMPLEX WITH INHIBITOR Heteromer
604-855
3KM;
Assess
Crystal structure of matriptase in complex with inhibitor Heteromer
604-855
NTX;
Assess
Crystal structure of membrane-type serine protease 1 (MT-SP1) in complex with the Fab Inhibitor S4 Heteromer
615-855
10×EDO;NA;CL;
Assess
Crystal Structure of MT-SP1 in complex with SFTI-1 Heteromer
Q4GWU5;
615-855
GSH;
Assess
Crystal Structure of Matriptase in complex with its inhibitor HAI-1 Heteromer
O43278;
615-855
GSH;GOL;PEG;PGE;
Assess
Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition. Heteromer
615-855
GLC;GOL;
Assess
Crystal Structure of MT-SP1 in complex with Fab Inhibitor E2 Heteromer
P01764;
615-855
EDO;SO4;
Assess
Crystal Structure of the inactive Matriptase in complex with its inhibitor HAI-1 Heteromer
O43278;
615-855
PG4;GOL;PGE;GSH;
Assess
Crystal Structure of Matriptase in complex with its inhibitor HAI-1 Heteromer
O43278;
615-855
PG4;GSH;
Assess
Crystal structure of the MTSP1 (matriptase)-BPTI (aprotinin) complex Heteromer
P00974;
615-855
Assess
Crystal structure of the zymogen matriptase catalytic domainmonomer604-855
SO4;
Assess
Crystal Structure of MT-SP1 bound to Benzamidine Phosphonate Inhibitormonomer615-855
CCZ;FMT;
Assess
Crystal Structure of MT-SP1 in complex with benzamidinemonomer615-855
SO4;EDO;BEN;GSH;
Assess
Crystal Structure Matriptase (C731S) in Complex with Inhibitor VD4162Bmonomer615-855
CL;
Assess
Crystal structure of MTSP1 (matriptase)monomer615-855
SO4;BEN;
Assess
Crystal Structure of the ligand-free inactive Matriptasemonomer615-855
SO4;GOL;GSH;
Assess
Matriptase in complex with the synthetic inhibitor (S)-3-(3-(4-(3-(tert-butyl)ureido)piperidin-1-yl…monomer615-855
CL;MXH;
Assess
Crystal Structure of Matriptase in complex with Inhibitormonomer615-855
F4D;
Assess
Crystal structure of Matriptase1 in complex with a peptidomimetic benzothiazolemonomer615-855
MG;EOH;GSH;KD7;144;
Assess
Crystal Structure of Matriptase in complex with Inhibitormonomer615-855
N4A;
Assess
Crystal Structure of Matriptase in complex with Inhibitor".monomer615-855
N4C;
Assess
Crystal Structure of Matriptase with Inhibitor CJ-730monomer615-855
730;
Assess
Structure of Matriptase in Complex with Inhibitor CJ-672monomer615-855
672;
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8vgt.1.Bmonomer0.60506-854
33.72
Assess
7wqx.1.Amonomer0.57338-853
34.26
Assess
7wqx.1.Amonomer0.54333-850
38.06
Assess
7f59.1.Emonomer0.50214-487
21.97
Assess